Assignee
CROOKS PETER A
US·8 granted patents·3 pending applications·39 citations·filing 2004–2012
Top patents by PatentIndex Score
11 records- 0194US8124652B2Use of parthenolide derivatives as antileukemic and cytotoxic agentsCROOKS PETER A·Filed 2010·Granted Feb 28, 2012·12 cites·43 claims
- 0291US8470875B2Use of parthenolide derivatives as antileukemic and cytotoxic agentsCROOKS PETER A·Filed 2012·Granted Jun 25, 2013·6 cites·29 claims
- 0379US7759358B2Oral bioavailable prodrugsCROOKS PETER A·Filed 2004·Granted Jul 20, 2010·11 cites·10 claims
- 0476US8884027B2Melampomagnolide B derivatives as antileukemic and cytotoxic agentsCROOKS PETER A·Filed 2011·Granted Nov 11, 2014·7 cites·23 claims
- 0573US8101779B2Enantioselective synthesis of (+) and (–)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-eneCROOKS PETER A·Filed 2009·Granted Jan 24, 2012·2 cites·21 claims
- 0666US8629163B2Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptorsCROOKS PETER A·Filed 2008·Granted Jan 14, 2014·1 cites·19 claims
- 0765US8304421B2Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agentsCROOKS PETER A·Filed 2009·Granted Nov 6, 2012·0 cites·14 claims
- 0852US8546415B2Bis-pyridino containing compounds for the use in the treatment of CNS pathologiesCROOKS PETER A·Filed 2010·Granted Oct 1, 2013·0 cites·16 claims
- 0951US2009118331A1Use of Lobeline Epimers in the Treatment of Central Nervous System Diseases, Pathologies, and Drug AbuseCROOKS PETER A·Filed 2008·Application pending·0 cites
- 1051US2006009468A1Method for treatment of cancerCROOKS PETER A·Filed 2005·Application pending·0 cites
- 1149US2005261334A1Bis-pyridino containing compounds for the use in the treatment of CNS pathologiesCROOKS PETER A·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CROOKS PETER A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →